Hypertension, insulin resistance and atherosclerosis
Related Experiment Video
Updated: Oct 17, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
1Department of Cardiology, Institute of Postgraduate Medical Education & Research, Calcutta.
Insights
Insulin resistance is linked to hypertension and other cardiovascular risks in many patients. Managing hypertension should aim to improve insulin sensitivity and reduce heart disease risk.
Area of Science:
- Cardiovascular Medicine
- Metabolic Syndrome
Background:
- Insulin resistance is a common factor in hypertension.
- Insulin resistance is associated with atherosclerosis and coronary artery disease risk factors like obesity, glucose intolerance, dyslipidemia, and hypercoagulability.
Purpose of the Study:
- To highlight the association between hypertension and insulin resistance.
- To define Insulin Resistance Syndrome (IRS) and its components.
- To guide clinicians in identifying at-risk hypertensive patients.
Main Methods:
- Review of existing literature on hypertension and insulin resistance.
- Clinical observation of associated metabolic and cardiovascular risk factors.
Main Results:
- A significant number of hypertensive patients exhibit insulin resistance.
- Insulin resistance is the common denominator for a cluster of metabolic abnormalities defining IRS.
- Associated conditions include obesity, glucose intolerance, dyslipidemia (low HDL, high triglycerides), and hypercoagulability.
Conclusions:
- Clinicians must identify hypertensive individuals with or at risk for IRS.
- Antihypertensive therapy should be tailored to improve insulin sensitivity.
- Therapeutic strategies should aim to minimize atherosclerotic coronary heart disease risk in these patients.
Abstract:
Hypertension, in a sizable number of patients, though not all, is associated with and possibly caused by insulin resistance. The later is also associated with a cluster of other risk factors of atherosclerosis and coronary artery disease, namely, obesity, glucose intolerance with or without overt diabetes, hypercholesterolaemia, low high density lipoprotein (HDL), hypertriglyceridaemia, hypercoagulability, etc. Currently, all these disorders are together called insulin resistance syndrome (IRS) as insulin resistance is the common denominator of these abnormalities. The clinicians should identify the individuals who are at risk or already have manifestations of IRS, especially among the hypertensives, and direct their antihypertensive therapy to improve insulin sensitivity and to minimise atherosclerotic coronary heart disease.
Related Concept Videos
Hypertension II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Coronary Artery Disease I: Introduction
Hypertension and Regulation of Blood Pressure
Diabetic Nephropathy
